Boston Scientific (BSX) Cash from Operations Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | -12.60% |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn | 18.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.62% |
| Mar 31, 2026 | -35.67% |
| Dec 31, 2025 | -6.32% |
| Sep 30, 2025 | 34.03% |
| Jun 30, 2025 | 58.18% |
| Mar 31, 2025 | 229.88% |
| Dec 31, 2024 | 52.14% |
| Sep 30, 2024 | 43.55% |
| Jun 30, 2024 | 23.56% |
| Mar 31, 2024 | -13.68% |
| Dec 31, 2023 | 18.59% |
| Sep 30, 2023 | 48.51% |
| Jun 30, 2023 | 114.33% |
| Mar 31, 2023 | 427.59% |
| Dec 31, 2022 | 68.83% |
| Sep 30, 2022 | 1.08% |
| Jun 30, 2022 | -52.26% |
| Mar 31, 2022 | -120.42% |
| Dec 31, 2021 | -28.97% |
| Sep 30, 2021 | -27.68% |